Norsk Patenttidende nr 09/05 - Patentstyret
Norsk Patenttidende nr 09/05 - Patentstyret
Norsk Patenttidende nr 09/05 - Patentstyret
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
allment tilgjengelige patentsøknader (A) 20<strong>05</strong>.02.28 - <strong>nr</strong> <strong>09</strong>/<strong>05</strong><br />
(51) Klasse : C07D 413/04<br />
A61K 031/506<br />
A61P 035/00<br />
(21) Søknads<strong>nr</strong> : 20044135<br />
(22) Inndag : 2004.<strong>09</strong>.29<br />
(41) Allm.tilgj : 2004.<strong>09</strong>.29<br />
(30) Prioritet : 2002.03.13, US, 363799<br />
2002.12.23, WO, PCT/EP02/14833<br />
(86) Int.inndag : 2003.03.11<br />
(86) Int.søknads<strong>nr</strong> : PCT/EP03/02510<br />
(24) Løpedag 2003.03.11<br />
(71) Søker<br />
Janssen Pharmaceutica NV , Turnhoutseweg 30, 2340<br />
BEERSE, BE<br />
(74) Fullmektig<br />
Oslo Patentkontor AS , Postboks 7007 Majorstua, 0306<br />
OSLO, NO<br />
(72) Oppfinner<br />
Kristof van Emelen, c/o Janssen Pharmaceutica NV,<br />
Turnhoutseweg 30, BEERSE, 2340, BE<br />
(54) Benevnelse<br />
Piperazinyl-, piperidinyl- og morfolinylderivater som nye<br />
inhibitorer av histon-deacetylase<br />
(51) Klasse : C07D 401/04<br />
C07D 403/04<br />
C07D 401/14<br />
A61K 031/404<br />
A61P 025/00<br />
(21) Søknads<strong>nr</strong> : 20044432<br />
(22) Inndag : 2004.10.19<br />
(41) Allm.tilgj : 2004.10.19<br />
(30) Prioritet : 2002.03.28, SE, 020<strong>09</strong>79<br />
(86) Int.inndag : 2003.03.28<br />
(86) Int.søknads<strong>nr</strong> : PCT/SE03/0<strong>05</strong>08<br />
(24) Løpedag 2003.03.28<br />
(71) Søker<br />
AstraZeneca AB , 15185 SÖDERTÄLJE, SE<br />
(74) Fullmektig<br />
Zacco Norway AS , Postboks 765 Sentrum, 0106 OSLO,<br />
NO<br />
(72) Oppfinner<br />
Martin Nylöf, c/o AstraZeneca R & D, SÖDERTÄLJE,<br />
15185, SE<br />
Stefan Berg, c/o AstraZeneca R&D Södertälje,<br />
SÖDERTÄLJE, 15185, SE<br />
Sven Hellberg, c/o AstraZeneca R&D Södertälje,<br />
SÖDERTÄLJE, 15185, SE<br />
Yafeng Xue, c/o AstraZeneca R & D, SÖDERTÄLJE,<br />
15185, SE<br />
(54) Benevnelse<br />
Nye forbindelser<br />
(51) Klasse : C07D 403/04<br />
A61K 031/5<strong>05</strong><br />
A61P 029/00<br />
(21) Søknads<strong>nr</strong> : 20044413<br />
(22) Inndag : 2004.10.18<br />
(41) Allm.tilgj : 2004.10.18<br />
(30) Prioritet : 2002.03.19, US, 365701<br />
(86) Int.inndag : 2003.03.12<br />
(86) Int.søknads<strong>nr</strong> : PCT/US03/07635<br />
(24) Løpedag 2003.03.12<br />
(71) Søker<br />
The Procter & Gamble Company , One Procter & Gamble<br />
Plaza, OH45202 CINCINNATI, US<br />
(74) Fullmektig<br />
Oslo Patentkontor AS , Postboks 7007 Majorstua, 0306<br />
OSLO, NO<br />
(72) Oppfinner<br />
Biswanath De, 11269 Cornell Woods Drive, CINCINNATI,<br />
OH45241, US<br />
Matthew John Laufersweiler, 6590 Black Forest Court,<br />
MORROW, OH45152, US<br />
Michael Phillip Clark, 1<strong>05</strong>63 S. State Route 48,<br />
LOVELAND, OH45140, US<br />
Jane Far-Jine Djung, 5747 W. Fountain Cr., MASON,<br />
OH45040, US<br />
Michael George Natchus, 555 Waterview Trail,<br />
ALPHARETTA, GA30022, US<br />
Cynthia Monesa Crago, 1<strong>05</strong>63 S State Route 48,<br />
LOVELAND, OH45140, US<br />
(54) Benevnelse<br />
1,2-Dihydropyrazol-3-oner som cytokinmediatorer<br />
(51) Klasse : C07D 239/91<br />
A61K 031/5025<br />
A61P 029/00<br />
(21) Søknads<strong>nr</strong> : 20044041<br />
(22) Inndag : 2004.<strong>09</strong>.24<br />
(41) Allm.tilgj : 2004.10.07<br />
(30) Prioritet : 2002.03.08, EP, 0203240<br />
(86) Int.inndag : 2003.03.06<br />
(86) Int.søknads<strong>nr</strong> : PCT/EP03/02277<br />
(24) Løpedag 2003.03.06<br />
(71) Søker<br />
Warner-Lambert Company LLC , 201 Tabor Road,<br />
NJ07950 MORRIS PLAINS, US<br />
(74) Fullmektig<br />
Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />
(72) Oppfinner<br />
Catherine Kostlan, c/o Pfizer Global Research and<br />
Development, 2800 Plymouth Road, ANN ARBOR,<br />
MI481<strong>05</strong>, US<br />
Bernard Gaudilliere, c/o Pfizer Global Research and<br />
Development, Ramsgate Road, SANDWICH, KENT,<br />
CT139NJ, GB<br />
He<strong>nr</strong>y Jacobelli, c/o Pfizer Global Research and<br />
Development, Ramsgate Road, SANDWICH, KENT,<br />
CT139NJ, GB<br />
Jack Li, c/o Pfizer Global Research and Development,<br />
2800 Plymouth Road, ANN ARBOR, MI481<strong>05</strong>, US<br />
Wen-Song Yue, c/o Pfizer Global Research and<br />
Development, 2800 Plymouth Road, ANN ARBOR,<br />
MI481<strong>05</strong>, US<br />
(54) Benevnelse<br />
Okso-azabisykliske forbindelser<br />
85